Navigation Links
Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs

hat regulates the biosynthesis of the inflammatory cytokines TNF, IL-6 and IL-1. Array scientists have discovered potent MEK inhibitors that interfere with these biosynthetic processes. We have previously advanced one MEK inhibitor, ARRY-886, into clinical development for the treatment of cancer. Given our experience with the safety profile of MEK inhibitors, we believe inhibition of MEK will have broad applications in diseases driven by IL-1 and TNF. ARRY-162, an orally active MEK inhibitor, has shown significant efficacy and is well tolerated in preclinical models of human arthritis and other inflammatory diseases.

About ARRY-797 / Targeting p38 for Inflammation and Cancer

P38 is a kinase target that regulates the production of numerous pro-inflammatory cytokines, in particular, TNF, IL-6 and IL-1. These cytokines can also act as cellular growth factors and are often up-regulated in certain cancers including prostate, ovarian and multiple myeloma. Additionally, p38 may play a role in certain resistance mechanisms or metastatic progression in cancer.

About Array BioPharma:

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life-threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

Array BioPharma's Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to future clinical test
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:12/19/2014)... 19, 2014  Monarch America Inc. (OTCQB: CANK) ("Monarch ... pleased to provide this review of the Company,s recent ... "Over this past year, we achieved many ... extremely proud to say that Monarch America is in ... has ever been," stated Eric Hagen , CEO ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
(Date:12/19/2014)... 18, 2014 Research and Markets ... the "Micro Market Monitor: North American Dermatology ... http://photos.prnewswire.com/prnh/20130307/600769 ... steadily, which has resulted in fueling the overall ... main purpose of these dermatology devices is to ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... Feb. 4, 2011 Novo Nordisk announced today ... mobile application (app) to assist in the diagnosis ... Craig Kessler, MD, Professor of Medicine and Pathology ... Hospital, Lombardi Comprehensive Cancer Center. Coags Uncomplicated features ...
... or "Company") (Nasdaq: UNIS ; ASX: UNS) announced ... the fiscal 2011 second quarter ended December 31, 2010 after ... Management has scheduled a conference call for 4:30 p.m. ... February 15 at 8:30 a.m. AEDT) , to review the ...
Cached Medicine Technology:Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders 2Unilife Corporation to Announce Financial Results for Fiscal 2011 Second Quarter on Monday, February 14, 2011 2
(Date:12/19/2014)... (PRWEB) December 19, 2014 ... dedicated to developing educational events, tools and resources ... Rouxbe Cooking School , the world’s leading online ... prescription every human being needs: Culinary Rx. As ... cooking course, Culinary Rx, scheduled for debut spring ...
(Date:12/19/2014)... CA (PRWEB) December 19, 2014 SuperCloset ... 5x5 SuperClone Rooms. SuperCloset continues to offer indoor growers ... Pair one of the new SuperClone Rooms with the ... perpetual, and turnkey indoor hydroponic grow room setup. , ... the world, SuperCloset’s SuperPonic SuperCloner 50 . ...
(Date:12/19/2014)... Albany, NY (PRWEB) December 20, 2014 ... Africa, Russia, and other nations. Around 151,000 tons of ... on year. The global vanadium usage increased at 6.7% ... which, the steel and iron industry, being the largest ... industry in 2013, followed by titanium-vanadium alloy and the ...
(Date:12/19/2014)... TX (PRWEB) December 20, 2014 The ... a new injectable filler from respected cosmetic brand Juvéderm. ... occur naturally with age. The Medspa at Hendrick is ... development in skin care technology to its clients. , ... gel to be FDA-approved to treat the mid-face and ...
(Date:12/19/2014)... warns parents that buying an older car for their teens may ... drivers killed in the United States between 2008 and 2012 were ... lacked important safety features that are available on newer cars, the ... were in cars at least six years old, 34 percent were ... cars 11 to 15 years old, and 17 percent were in ...
Breaking Medicine News(10 mins):Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Older Cars a Bad Choice for Younger Drivers 2
... Outside Board Meeting, MARTINEZ, Calif., Nov. 26 ... place outside Tuesday,s meeting of the Contra,Costa Board ... The 150,000-member SEIU United Healthcare Workers-West is ... United States and represents,every type of healthcare worker, ...
... cholera, a potentially fatal,diarrheal disease found in the ... orally vaccinating half of the affected,populations once every ... to,new findings by an international team of researchers ... in the Vaccine and Infectious Disease,Institute at Fred ...
... experience stigma, loneliness and ostracism, and can find it ... new research findings. , They also struggle to ... though, in theory, there is 100% access to state-funded ... result. , Sarah Bernays, of the London School of ...
... 26 The Wackenhut,Corporation, the leading security services ... to enhance its employee medical and dental,insurance plans ... further validation that Wackenhut,s focus on employee welfare ... consulting firm, Mercer, released an overview of,its most ...
... ... Marine Underwriters, CANTON, Mass., Nov. 26 ... Southern Marine,& Aviation Inc., to represent its International Marine Underwriters (IMU),division. ... under a primary marine cargo program managed by Southern Marine &,Aviation, ...
... Datascope Urges Shareholders to Re-Elect Incumbent Directors and Reject ... ... Datascope Corp.,(Nasdaq: DSCP ) today filed an investor ... available on the Investor,Relations section of the Company,s website at ...
Cached Medicine News:Health News:Study Shows Cholera Can be Controlled With Oral Vaccines 2Health News:Study Shows Cholera Can be Controlled With Oral Vaccines 3Health News:New study highlights stigma and stress of living with HIV/AIDS in Serbia 2Health News:New study highlights stigma and stress of living with HIV/AIDS in Serbia 3Health News:Wackenhut Enhances Health Insurance Plans Without Raising Costs 2Health News:OneBeacon Appoints Southern Marine & Aviation Inc. 2Health News:OneBeacon Appoints Southern Marine & Aviation Inc. 3Health News:OneBeacon Appoints Southern Marine & Aviation Inc. 4Health News:Datascope Files Investor Presentation 2Health News:Datascope Files Investor Presentation 3Health News:Datascope Files Investor Presentation 4Health News:Datascope Files Investor Presentation 5Health News:Datascope Files Investor Presentation 6Health News:Datascope Files Investor Presentation 7Health News:Datascope Files Investor Presentation 8
Digital Ambulatory ECG Recorder...
... ECG-9320 is a full-featured ECG ... IEC60601-2-51 new international standard for ... digital filter performance. The ECG ... managed on a Windows PC ...
... IEC60601-2-51 new international standard for digital ... performance. ECG data can be reviewed ... with the optional ECG Viewer software. ... in other countries, and it truly ...
... pHOx series consists of six analyzer models providing ... profiles. Measured tests include pH, PCO 2 , ... sodium, potassium, ionized calcium, chloride, glucose, and lactate. ... minute. Its space saving design provides the smallest ...
Medicine Products: